Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
300858 Beijing Scitop Bio-tech
- 16.00
- +1.66+11.58%
Market Closed Apr 24 15:00 CST
4.22BMarket Cap43.84P/E (TTM)
16.63High14.05Low257.30KlotVolume14.49Open14.34Pre Close397.08MTurnover13.57%Turnover Ratio44.69P/E (Static)263.50MShares19.9752wk High2.33P/B3.03BFloat Cap11.0352wk Low17.21Limit Up189.55MShs Float37.15Historical High11.47Limit Down17.99%Amplitude10.53Historical Low0.15Dividend TTM15.43Avg Price92.67KlotAsk0.94%Div YieldTTM100Lot Size149.12KlotBid
Beijing Scitop Bio-tech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -21.73%65.47M | 5.66%371.56M | -14.76%243.67M | -18.30%162.73M | -29.53%83.65M | -19.27%351.64M | -5.76%285.88M | -8.29%199.19M | 11.28%118.7M | -3.41%435.58M |
| Refunds of taxes and levies | ---- | 419.07%21.64M | ---- | ---- | ---- | 14,720.25%4.17M | ---- | ---- | ---- | -90.52%28.13K |
| Cash received relating to other operating activities | -66.32%1.49M | 74.95%31.43M | 263.24%52.26M | 19.17%15.14M | -43.96%4.43M | 109.19%17.96M | 73.51%14.39M | 77.54%12.71M | 111.08%7.9M | -23.46%8.59M |
| Cash inflows from operating activities | -23.97%66.96M | 13.60%424.63M | -1.44%295.93M | -16.06%177.88M | -30.43%88.08M | -15.85%373.78M | -4.22%300.26M | -6.04%211.9M | 14.67%126.6M | -3.95%444.19M |
| Goods services cash paid | 82.38%30.53M | 9.21%119.1M | -27.56%68.72M | -42.35%43.78M | -67.44%16.74M | -39.39%109.06M | -23.77%94.87M | -14.95%75.95M | 15.13%51.4M | -21.43%179.95M |
| Staff behalf paid | 4.96%22.03M | 8.21%64.32M | 5.82%49.97M | 6.10%35.09M | 4.22%20.99M | 13.43%59.44M | 13.44%47.22M | 13.29%33.08M | 21.50%20.14M | 2.68%52.4M |
| All taxes paid | -56.38%5.23M | -4.90%47.36M | -11.70%31.59M | -28.24%22.41M | -34.43%11.98M | 64.84%49.81M | 75.30%35.77M | 204.83%31.22M | 443.64%18.27M | -17.85%30.22M |
| Cash paid relating to other operating activities | 0.56%9.71M | 7.32%51.73M | -7.59%38M | 1.53%26.38M | -30.57%9.65M | 45.33%48.2M | 62.34%41.12M | 65.37%25.98M | 50.54%13.9M | -6.20%33.17M |
| Cash outflows from operating activities | 13.69%67.49M | 6.00%282.51M | -14.02%188.27M | -23.20%127.66M | -42.77%59.36M | -9.88%266.51M | 3.39%218.98M | 15.08%166.23M | 40.50%103.72M | -16.03%295.74M |
| Net cash flows from operating activities | -101.84%-529.72K | 32.49%142.11M | 32.44%107.66M | 9.95%50.21M | 25.50%28.71M | -27.75%107.27M | -20.07%81.28M | -43.66%45.67M | -37.46%22.88M | 34.63%148.46M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -25.31%456.34M | 65.38%2.45B | 32.92%1.69B | 30.90%1.24B | 17.47%611M | -13.75%1.48B | 9.13%1.27B | 2.87%945.77M | -2.55%520.12M | 1.03%1.71B |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -99.21%415 | -36.77%595 | -36.77%595 | ---- | 9,361.54%52.75K | --940.97 | --940.97 | --410 | -99.99%557.52 |
| Cash inflows from investing activities | -25.31%456.34M | 65.37%2.45B | 32.92%1.69B | 30.90%1.24B | 17.47%611M | -13.75%1.48B | 9.13%1.27B | 2.87%945.77M | -2.55%520.12M | -0.00%1.71B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 76.48%95.44M | 18.50%211.5M | 10.68%148.99M | 12.21%92.09M | 74.70%54.08M | 112.02%178.47M | 400.25%134.61M | 417.05%82.07M | 199.03%30.95M | 24.58%84.18M |
| Cash paid to acquire investments | -50.07%248.14M | 18.54%2.42B | -1.28%1.66B | -20.73%1.27B | -57.92%496.97M | 1.84%2.04B | 11.77%1.69B | 35.80%1.6B | 55.36%1.18B | 43.69%2B |
| Net cash paid to acquire subsidiaries and other business units | --10M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | --3M | --3M | ---- | ---- |
| Cash outflows from investing activities | -35.83%353.58M | 18.54%2.63B | -0.56%1.81B | -19.27%1.36B | -54.54%551.05M | 6.28%2.22B | 18.77%1.82B | 41.11%1.69B | 57.29%1.21B | 42.80%2.09B |
| Net cash flows from investing activities | 71.39%102.76M | 75.08%-184.33M | 77.33%-125.53M | 83.40%-122.84M | 108.66%59.96M | -98.29%-739.71M | -48.96%-553.78M | -168.86%-739.99M | -192.15%-691.96M | -247.70%-373.04M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --693.83M |
| Cash inflows from financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --693.83M |
| Dividend interest payment | ---- | -25.00%39.52M | -25.05%39.5M | -56.02%22.34M | ---- | -29.23%52.7M | -29.23%52.7M | -28.63%50.8M | ---- | -9.76%74.46M |
| Cash payments relating to other financing activities | -88.01%416.09K | -25.35%1.21M | 2.14%4.09M | 4.65%3.94M | 32.38%3.47M | 29.89%1.62M | 318.32%4M | 365.86%3.77M | 2,014.82%2.62M | 58.25%1.25M |
| Cash outflows from financing activities | -88.01%416.09K | -25.01%40.73M | -23.13%43.59M | -51.83%26.28M | 32.38%3.47M | -28.25%54.32M | -24.82%56.7M | -24.20%54.57M | 2,014.82%2.62M | -9.12%75.71M |
| Net cash flows from financing activities | 88.01%-416.09K | 25.01%-40.73M | 23.13%-43.59M | 51.83%-26.28M | -32.38%-3.47M | -108.79%-54.32M | 17.92%-56.7M | 16.88%-54.57M | -2,014.82%-2.62M | 841.99%618.12M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---0.85 | --31.32 | ---202.65 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | 19.50%101.82M | 87.92%-82.95M | 88.39%-61.46M | 86.79%-98.91M | 112.68%85.2M | -274.51%-686.76M | -56.04%-529.2M | -188.23%-748.89M | -235.19%-671.7M | 40.78%393.54M |
| Add:Begin period cash and cash equivalents | -44.00%105.59M | -78.46%188.54M | -78.46%188.54M | -78.46%188.54M | -78.46%188.54M | 81.69%875.3M | 81.69%875.3M | 81.69%875.3M | 81.69%875.3M | 138.22%481.76M |
| End period cash equivalent | -24.23%207.4M | -44.00%105.59M | -63.28%127.07M | -29.10%89.62M | 34.45%273.74M | -78.46%188.54M | 142.66%346.1M | -43.05%126.4M | -27.64%203.6M | 81.69%875.3M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs